メベンダゾール複合体とHPベータサイクロデクストリンの製薬と薬理学研究
Charles Ding1,2, Yili Ding1,3, Zhe Xu1
1College of Science, Mathematics and Technology, Wenzhou-Kean University, Wenzhou, China.
Frontiers in veterinary science
|August 25, 2025
まとめ
科学者は新しいメベンダゾール製剤を開発し,水溶性と生物利用性を大幅に高めました. メベンダゾルを強化する
科学分野:
- 医薬品科学
- 薬物投与システム
- 腫瘍学
背景:
- メベンダゾールは1974年からFDAが承認した抗寄生剤で,抗がん性があることが実証されています.
- メベンダゾールの水溶性の低下 (< 0. 33 μg/ mL) は,がん治療における臨床応用を歴史的に制限している.
研究 の 目的:
- メベンダゾルの高度な配列を開発し,水溶性を高め,抗がん用途の薬理学特性を改善する.
主な方法:
- メベンダゾールとヒドロキシプロピル-β-サイクロデクストリン (HP-β-サイクロデクストリン) を併用して溶解性を改善する.
- 放出運動を評価する試験
- 生物利用性と薬物曝露を評価するために犬のモデルでのin vivo薬動学的研究.
主要な成果:
- メベンダゾール-HP-ベータ-サイクロデクストリン複合体は,溶解度が6. 05 mg/ ml,つまり18, 333倍に達した.
- In vitro試験では,メベンダゾールの80%が5分以内に複合体から放出され,純薬の20%と比較した.
- in vivo試験では,Cmaxが上昇し,半減期が延長され,AUC0−24が増加した.
結論:
- メベンダゾール-HP-β-サイクロデクストリン製剤はメベンダゾールの溶解性と生物利用性を著しく高めています.
- この製剤はメベンダゾルを臨床実用における有効な抗がん治療薬として開発する有望な可能性を示しています.
関連する概念動画
01:17Hepatic Drug Excretion: Enterohepatic Cycling
1.7K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.7K
01:16Methods for Studying Drug Absorption: In vitro
332
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
332
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
262
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
262